259 related articles for article (PubMed ID: 31883914)
21. Repurposing quinacrine for treatment-refractory cancer.
Oien DB; Pathoulas CL; Ray U; Thirusangu P; Kalogera E; Shridhar V
Semin Cancer Biol; 2021 Jan; 68():21-30. PubMed ID: 31562955
[TBL] [Abstract][Full Text] [Related]
22. Machine and deep learning approaches for cancer drug repurposing.
Issa NT; Stathias V; Schürer S; Dakshanamurthy S
Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
[TBL] [Abstract][Full Text] [Related]
23. Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy.
Shaw V; Srivastava S; Srivastava SK
Semin Cancer Biol; 2021 Jan; 68():75-83. PubMed ID: 31618686
[TBL] [Abstract][Full Text] [Related]
24. Drug repurposing for breast cancer therapy: Old weapon for new battle.
Aggarwal S; Verma SS; Aggarwal S; Gupta SC
Semin Cancer Biol; 2021 Jan; 68():8-20. PubMed ID: 31550502
[TBL] [Abstract][Full Text] [Related]
25. Drug repositioning in cancer: The current situation in Japan.
Masuda T; Tsuruda Y; Matsumoto Y; Uchida H; Nakayama KI; Mimori K
Cancer Sci; 2020 Apr; 111(4):1039-1046. PubMed ID: 31957175
[TBL] [Abstract][Full Text] [Related]
26. Repurposing of drugs as STAT3 inhibitors for cancer therapy.
Thilakasiri PS; Dmello RS; Nero TL; Parker MW; Ernst M; Chand AL
Semin Cancer Biol; 2021 Jan; 68():31-46. PubMed ID: 31711994
[TBL] [Abstract][Full Text] [Related]
27. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.
Advani D; Gupta R; Tripathi R; Sharma S; Ambasta RK; Kumar P
Neurochem Int; 2020 Nov; 140():104841. PubMed ID: 32853752
[TBL] [Abstract][Full Text] [Related]
28. Small-molecule drug repurposing to target DNA damage repair and response pathways.
Brinkman JA; Liu Y; Kron SJ
Semin Cancer Biol; 2021 Jan; 68():230-241. PubMed ID: 32113999
[TBL] [Abstract][Full Text] [Related]
29. Current progress and future perspectives of polypharmacology : From the view of non-small cell lung cancer.
Karuppasamy R; Veerappapillai S; Maiti S; Shin WH; Kihara D
Semin Cancer Biol; 2021 Jan; 68():84-91. PubMed ID: 31698087
[TBL] [Abstract][Full Text] [Related]
30. Identification of Drug Candidates for Breast Cancer Therapy Through Scaffold Repurposing: A Brief Review.
Selvaraj J; Prabha T; Yadav N
Curr Drug Res Rev; 2021; 13(1):3-15. PubMed ID: 32838729
[TBL] [Abstract][Full Text] [Related]
31. Repurposing Chloroquine Analogs as an Adjuvant Cancer Therapy.
Fong W; To KKW
Recent Pat Anticancer Drug Discov; 2021; 16(2):204-221. PubMed ID: 33413069
[TBL] [Abstract][Full Text] [Related]
32. Drug repurposing a compelling cancer strategy with bottomless opportunities: Recent advancements in computational methods and molecular mechanisms.
Dash R; Yadav M; Biswal J; Samanta S; Sharma T; Mohapatra S
Indian J Pharmacol; 2023; 55(5):322-331. PubMed ID: 37929411
[TBL] [Abstract][Full Text] [Related]
33. Drug repurposing-an emerging strategy in cancer therapeutics.
Turabi KS; Deshmukh A; Paul S; Swami D; Siddiqui S; Kumar U; Naikar S; Devarajan S; Basu S; Paul MK; Aich J
Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1139-1158. PubMed ID: 35695911
[TBL] [Abstract][Full Text] [Related]
34. Overcoming cancer therapeutic bottleneck by drug repurposing.
Zhang Z; Zhou L; Xie N; Nice EC; Zhang T; Cui Y; Huang C
Signal Transduct Target Ther; 2020 Jul; 5(1):113. PubMed ID: 32616710
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy.
Rauf A; Joshi PB; Olatunde A; Hafeez N; Ahmad Z; Hemeg HA; Aljohani ASM; Al Abdulmonem W; Thiruvengadam M; Viswanathan D; Rajakumar G; Thiruvengadam R
Med Oncol; 2024 Apr; 41(5):122. PubMed ID: 38652344
[TBL] [Abstract][Full Text] [Related]
36. What patents tell us about drug repurposing for cancer: A landscape analysis.
Mucke HAM
Semin Cancer Biol; 2021 Jan; 68():3-7. PubMed ID: 31546010
[TBL] [Abstract][Full Text] [Related]
37. Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.
Chen H; Wu J; Gao Y; Chen H; Zhou J
Curr Top Med Chem; 2016; 16(19):2107-14. PubMed ID: 26881709
[TBL] [Abstract][Full Text] [Related]
38. Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential.
Lo YC; Senese S; France B; Gholkar AA; Damoiseaux R; Torres JZ
Sci Rep; 2017 Sep; 7(1):11261. PubMed ID: 28900159
[TBL] [Abstract][Full Text] [Related]
39. Repurposing old drugs to fight multidrug resistant cancers.
Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
[TBL] [Abstract][Full Text] [Related]
40. Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations.
Chan MM; Chen R; Fong D
Cancer Lett; 2018 Oct; 433():53-64. PubMed ID: 29960048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
